Asprosin in Behect Patients

Sponsor
Assiut University
Study ID
NCT07803198
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

This study aims to investigate serum Asprosin concentrations in patients with BD and their relationship with disease activity and major clinical manifestations.

Key Dates

First listed
Sep 3, 2026
Start date
Sep 1, 2026
Status verified
Aug 2026
Primary completion
Sep 30, 2027
Completion
Oct 30, 2027

Study Design

Enrollment
44 participants (estimated)

Primary Outcome Measure

Assessment of asprosin level in behcet disease and its association with disease activity [ Time Frame: Baseline ]

Central Contacts

Related Studies